Around 5% of T-ALL patients display chromosomal rearrangements or amplifications driving expression of NKX2–1, a homeodomain transcription factor that is not expressed during normal T-cell development [15, 18]. This evidence concerns the gene NKX2-1 and acute lymphoblastic leukemia.